Analysis Report on Geriatric Medicine Development Market New Opportunities - PowerPoint PPT Presentation

Loading...

PPT – Analysis Report on Geriatric Medicine Development Market New Opportunities PowerPoint presentation | free to download - id: 6c69a7-OGYwZ



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Analysis Report on Geriatric Medicine Development Market New Opportunities

Description:

Big Market Research, Geriatric Medicine Development Market Size, Share, Trends, Forecast, Opportunities, Development, Industry, Challenges, Outlook. More than 50% of prescriptions is written for people aged 65 years and older. Many older people suffer from comorbid conditions and one in three takes at least five drugs or more on a daily basis. This significantly increases the risk of Adverse Drug Events (ADEs) and hospitalization. Up to one third of emergency admissions in elderly people is drug-related – PowerPoint PPT presentation

Number of Views:12

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Analysis Report on Geriatric Medicine Development Market New Opportunities


1
Geriatric Medicine Development - Carving out New
Opportunities to Treat Age-related
Diseases www.bigmarketresearch.com
2
Report Description
About Geriatric Medicine Development Market Mo
re than 50 of prescriptions is written for
people aged 65 years and older. Many older people
suffer from comorbid conditions and one in three
takes at least five drugs or more on a daily
basis. This significantly increases the risk of
Adverse Drug Events (ADEs) and hospitalization.
Up to one third of emergency admissions in
elderly people is drug-related. There remains a
lack of clinical data to support prescription
decisions as relatively few medicines have been
clinically evaluated in age-appropriate patients.
In addition, many drugs are not available in
formulations that are suitable for the elderly,
leading to non-compliance and lack of therapeutic
efficacy. In 2011, the EMA introduced its
Geriatric Medicines Strategy to ensure that the
medical requirements of older people are
identified earlier in the drug development
process. In 2012, the ICH E7 guidelines were
revised to include a greater focus on involving
more geriatric patients in drug trials. Get More
Details At http//www.bigmarketresearch.com/geria
tric-medicine-development-carving-out-new-opportun
ities-to-treat-age-related-diseases-market
3
Report Description
  • Scope
  • - Reviews the current regulatory landscape and
    helps sponsors to understand the potential impact
    of recent guidelines.
  • - Assesses the barriers to entry in geriatric
    medicines and identifies potential ways to
    overcome them and improve clinical decision
    making.
  • - Evaluates the importance of establishing Target
    Quality Product Profiles (TQPP) to help sponsors
    determine the target patient population earlier
    on in drug development.
  • - Identifies treatment gaps and commercial
    opportunities based on primary care real-time
    data and KOL insights.
  • Analyses different strategies to develop
    age-appropriate medicines in niche therapeutic
    fields and discusses methods to encourage the
    smarter prescription of medicines.
  • Enquiry about Report _at_ http//www.bigmarketresearc
    h.com/report-enquiry/132505

4
Report Description
  • Key Reasons to Purchase
  • - Utilize the insights from this study to analyze
    the barriers facing the geriatrics market
  • Understand the impact of drug development in this
    market now and in the future
  • Find out why regulators are paying more attention
    to unnecessary exclusion criteria and
    encouraging the inclusion of older people to
    ensure trials are age-appropriate and more
    representative of the real world setting.
  • - Assess the opportunities available for
    companies to develop age-appropriate dosages and
    formulations for existing drug classes that are
    currently widely associated with ADEs in the
    elderly as well as new therapeutic prospects.

5
Table Of Content
Executive Summary Methodology Geriatric
medicines an overview Emerging issues Unmet
clinical needs Current landscape Regulatory
environment Political will for change Strategic
considerations for developing geriatric
medicines Barriers to developing geriatric drugs
Clinical trial considerations Get complete TOC
here _at_ http//www.bigmarketresearch.com/geriatric-
medicine-development-carving-out-new-opportunities
-to-treat-age-related-diseases-market
6
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/geriatric-medicin
e-development-carving-out-new-opportunities-to-tre
at-age-related-diseases-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (855) 711-1555E-MAIL
sales_at_bigmarketresearch.com
About PowerShow.com